Qube Research & Technologies LTD Ab Cellera Biologics Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$4.6 - $7.95 $124,048 - $214,387	26,967 New	26,967 $124,000
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $1.19 Million - $1.82 Million	-162,896 Reduced 63.01%	95,621 $720,000
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $1.96 Million - $3 Million	206,750 Added 399.39%	258,517 $2.62 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $476,256 - $708,172	51,767 New	51,767 $512,000
Q2 2022 Aug 15, 2022	SELL	$5.72 - $10.65 $854,665 - $1.59 Million	-149,417 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$7.46 - $14.14 $967,890 - $1.83 Million	129,744 Added 659.5%	149,417 $1.46 Million
Q4 2021 Feb 01, 2022	BUY	$12.99 - $17.73 $255,552 - $348,802	19,673 New	19,673 $281,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.